Investigating the collective advantages of sodium-glucose cotransporter-2 inhibitors and GLP-1 analogs in addressing metabolic health issues linked to obese type 2 diabetes mellitus and related comorbidities.

IF 1.4 4区医学 Q4 PHARMACOLOGY & PHARMACY

Indian Journal of Pharmacology Pub Date : 2025-03-01 Epub Date: 2025-06-13 DOI:10.4103/ijp.ijp_559_24

Sulthan Al-Rashid, Monisha Prasad, Rajkapoor Balasubramanian, Naina Mohamed Pakkir Maideen

引用次数: 0

查看原文本刊更多论文

研究钠-葡萄糖共转运蛋白-2抑制剂和GLP-1类似物在解决与肥胖2型糖尿病及相关合并症相关的代谢健康问题中的集体优势

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Indian Journal of Pharmacology 医学-药学

CiteScore

4.00

自引率

4.20%

发文量

审稿时长

4-8 weeks

期刊介绍： Indian Journal of Pharmacology accepts, in English, review articles, articles for educational forum, original research articles (full length and short communications), letter to editor, case reports and interesting fillers. Articles concerning all aspects of pharmacology will be considered. Articles of general interest (e.g. methods, therapeutics, medical education, interesting websites, new drug information and commentary on a recent topic) are also welcome.